BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

HUAWEI, Aligns With PLANO to Tackle the Global Problem of Myopia

Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem...

August 05, 2021 | News

Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China

111, Inc. , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in&nb...

August 04, 2021 | News

eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific

The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA’s increasi...

August 03, 2021 | News

Insilico ,Westlake to jointly develop innovative small-molecule drugs for COVID19

The cooperation will be based on the anti-COVID-19 drug R&D project by Westlake Pharma, which aims to develop broad-spectrum small molecule inhibitor d...

August 03, 2021 | News

Envirotainer Welcomes China Southern Airlines as the first mainland China carrier to approve the Releye® RLP

The Envirotainer Releye® RLP is a LD11-sized unit with a unique air flow technology for maximum temperature stability in the cargo bay. The RLP-size fi...

August 02, 2021 | News

Neukio Biotherapeutics completed its $40m Angel round financing

Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asi...

July 30, 2021 | News

Zhongchao To Promote the Equalization of Breast Cancer Diagnosis

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...

July 28, 2021 | News

WuXi Biologics Received First GMP manufacturing authorization outside of China

First GMP manufacturing authorization outside of China, validating WuXi Biologics' world-class quality system Only 12 months from facility qualific...

July 26, 2021 | News

I-Mab Expands Next Generation Novel Oncology Therapeutics

I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel bio...

July 10, 2021 | News

Univercells Tech and VectorBuilder announce partnership for optimized custom viral vector production

Agreement to encompass co-development and optimization of protocols for intensified and continuous viral vector production for cell and gene therapies and ...

July 07, 2021 | News

Arctic Vision to develop innovative therapies for pan-ocular diseases

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...

July 05, 2021 | News

RauCon Signs Second Partnership Agreement for Chinese Pharma Market

According to the agreements, RauCon will promote both companies’ service offers while Ling med and GBI will promote RauCon’s Marketplaces for P...

July 02, 2021 | News

I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio

First patient dosed in U.S. phase 1 clinical trial of TJ-CD4B/ABL111 in patients with advanced or metastatic solid tumors China sites to join the d...

July 02, 2021 | News

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

OnCusp successfully closed its seed round financing of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed b...

July 01, 2021 | News

Stay Connected